OSI Pharmaceuticals (OSIP) - formerly Oncogene Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DewDiligence_on_SI who wrote (342)	1/16/2006 12:34:15 AM
From: sammaster	Read Replies (1) of 447

do you think being a selective vegf inhibitor will not give it a better side effect profile than lucentis? do you think that tarceva growth can make up for the shortfall in macugen sales? or do you think their price has dropped far enough to discount loss of macugen sales already? thanks for your previous answer :) just trying to get a handle on this company... its been beaten down but has 2 drugs on market with potential for tarceva and dp4 inhibitors for strong growth...was thinking the beatdown from macugen is overdone?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next